FDA lists a once-weekly insulin approval for pediatric type 2 diabetes
The FDA's notable approvals list records its decision for Awiqli on October 23.
Read the FDA list ↗LENTOTECH / PHARMA INTELLIGENCE
Follow regulatory decisions, medicines and manufacturing developments. Each item links to its original source; dates identify the source entry or meeting.
The FDA's notable approvals list records its decision for Awiqli on October 23.
Read the FDA list ↗The October CHMP meeting included positive opinions for medicines across several therapeutic areas. The recommendations are subject to a European Commission decision.
Read the EMA report ↗Questions to use when discussing process knowledge, quality systems and technology transfer with potential partners.
Read the guide ↗